BioReperia AB
My visitor profile
BioReperia AB
Description of your activity
- BioReperia accelerates oncology drug development with a next-generation in-vivo platform using zebrafish embryos. Our fast, clinically relevant models provide efficacy data in just 5 days, supporting target validation, lead optimization, and precision medicine strategies, while reducing reliance on traditional animal models.
More information
-
๐ฅ๐ฒ๐๐ผ๐น๐๐๐ถ๐ผ๐ป๐ถ๐๐ถ๐ป๐ด ๐๐ฟ๐๐ด ๐๐ฒ๐๐ฒ๐น๐ผ๐ฝ๐บ๐ฒ๐ป๐ ๐๐ถ๐๐ต ๐๐ถ๐ผ๐ฅ๐ฒ๐ฝ๐ฒ๐ฟ๐ถ๐ฎโ๐ ๐ก๐ฒ๐
๐-๐๐ฒ๐ป๐ฒ๐ฟ๐ฎ๐๐ถ๐ผ๐ป ๐๐ป-๐ฉ๐ถ๐๐ผ ๐ฃ๐น๐ฎ๐๐ณ๐ผ๐ฟ๐บ
Innovation is essential to accelerate timelines and de-risk development in todayโs pharmaceutical landscape. BioReperiaโs cutting-edge in-vivo platform offers a rapid, clinically relevant, and highly translational solution to support your pipeline at every critical stage.
๐ง๐ฎ๐ฟ๐ด๐ฒ๐ ๐ฉ๐ฎ๐น๐ถ๐ฑ๐ฎ๐๐ถ๐ผ๐ป ๐๐ถ๐๐ต ๐ฃ๐ฟ๐ฒ๐ฐ๐ถ๐๐ถ๐ผ๐ป ๐ฎ๐ป๐ฑ ๐ฆ๐ฝ๐ฒ๐ฒ๐ฑ
Gain actionable efficacy data in just 5 days. Our models assess both tumor regression and metastasis dissemination using CDX, PDX, and primary patient tumors; enabling confident, early-stage decision-making.
๐๐ผ๐บ๐ฝ๐ฟ๐ฒ๐ต๐ฒ๐ป๐๐ถ๐๐ฒ ๐ฆ๐ฐ๐ฟ๐ฒ๐ฒ๐ป๐ถ๐ป๐ด ๐ณ๐ผ๐ฟ ๐๐น๐น ๐ง๐ต๐ฒ๐ฟ๐ฎ๐ฝ๐ฒ๐๐๐ถ๐ฐ ๐ ๐ผ๐ฑ๐ฎ๐น๐ถ๐๐ถ๐ฒ๐
From small molecules and peptides to antibodies, ADCs, and immunotherapies, our versatile platform supports screening across your entire portfolio within a single validated system.
๐๐ฐ๐ฐ๐ฒ๐น๐ฒ๐ฟ๐ฎ๐๐ถ๐ป๐ด ๐๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ง๐ฟ๐ถ๐ฎ๐น ๐ฅ๐ฒ๐ฎ๐ฑ๐ถ๐ป๐ฒ๐๐
ย ย โข Translational Accuracy: PDX and patient tumor models deliver insights that mirror clinical outcomes.
ย ย โข Precision Medicine-Ready: CE-certified and proven to help identify the right patients, faster.
ย ย โข Speed to First-in-Human: Rapid results enable timely go/no-go decisions, shortening the path to clinical trials.
Collaborate with us to de-risk development, optimize resources, and bring transformative therapies to patients, faster.
Social Networks
Participation objectives
Partnering objectives
- Network development, Customer development
Description of my participation objective
- We aim to understand current pain points in oncology drug development, explore collaboration opportunities, build lasting partnerships, and raise awareness of zebrafish embryos as a powerful and ethical alternative to traditional animal models.